BaseClear Competitors and Similar CompaniesClear all
BaseClear's competitors and similar companies include NEXT Molecular Analytics, Veracyte, Yourgene Health and Fulgent Genetics.
 NEXT Molecular Analytics NEXT Molecular Analytics (also known as NEXT Bio-Research Services) is a company focused on clinical testing using molecular and biochemical techniques. |  Veracyte Veracyte (formerly known as Calderome) is a genomic diagnostics company that specializes in molecular testing for the treatment of cancer. |  Yourgene Health Yourgene Health (formerly known as Premaitha Health) is an integrated technologies and services company specializing in genomic medicine. |  Fulgent Genetics Fulgent Therapeutics is a technology company offering large-scale COVID-19 testing services, molecular diagnostic testing services, and comprehensive genetic testing. | ||
Founding Date | Founding Date 1993 | Founding Date 2015 | Founding Date 2008 | Founding Date 2013 | Founding Date 2011 |
Type | Type Private | Type Private | Type Public | Type Subsidiary | Type Public |
Tags | |||||
Locations | Locations Leiden, NL HQ | Locations Chester, US HQ | Locations South San Francisco, US HQ Marseille, FR Haifa, IL Austin, US San Diego, US | Locations Manchester, GB HQ Port Coquitlam, CA Paris, FR Düsseldorf, DE Singapore, SG Taipei, TW Miami Beach, US | Locations Temple City, US HQ Houston, US |
Employees | Employees 642% decrease | Employees 13 | Employees 8154% increase | Employees 164 | Employees 1,01257% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 2.6 b | Valuation ($) N/A | Valuation ($) 606.8 m |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $517.1m (FY, 2025) | Revenue (est.) £37.6m (FY, 2022) | Revenue (est.) $322.7m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods £16.2m (FY, 2022) | Cost of goods $191.8m (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit $362.5m (FY, 2025) | Gross profit £21.4m (FY, 2022) | Gross profit $130.9m (FY, 2025) |
Net income | Net income N/A | Net income N/A | Net income $66.4m (FY, 2025) | Net income (£1.9m) (FY, 2022) | Net income ($61.6m) (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 116.3m | Total funding raised N/A | Total funding raised $ 34.9m |
For sources of this data, please see the company profile
View Company Profiles
NEXT Molecular Analytics
HQ
Chester, US
Employees
13
NEXT Molecular Analytics (also known as NEXT Bio-Research Services) is a company focused on clinical testing using molecular and biochemical techniques.
View companyVeracyte
HQ
South San Francisco, US
Employees
815↑ 4% increase
Veracyte (formerly known as Calderome) is a genomic diagnostics company that specializes in molecular testing for the treatment of cancer.
View companyYourgene Health
HQ
Manchester, GB
Yourgene Health (formerly known as Premaitha Health) is an integrated technologies and services company specializing in genomic medicine.
View companyFulgent Genetics
HQ
Temple City, US
Employees
1,012
Fulgent Therapeutics is a technology company offering large-scale COVID-19 testing services, molecular diagnostic testing services, and comprehensive genetic testing.
View company